Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adjuvants, Immunologic | 30 | 2024 | 1000 | 5.670 |
Why?
|
Vaccines | 26 | 2023 | 817 | 4.690 |
Why?
|
Immunity, Innate | 49 | 2022 | 2956 | 4.440 |
Why?
|
BCG Vaccine | 8 | 2022 | 367 | 4.230 |
Why?
|
Toll-Like Receptors | 28 | 2019 | 592 | 3.870 |
Why?
|
Toll-Like Receptor 8 | 10 | 2017 | 90 | 3.200 |
Why?
|
Blood Proteins | 22 | 2018 | 1122 | 2.620 |
Why?
|
Monocytes | 14 | 2021 | 2593 | 2.540 |
Why?
|
Infant, Newborn | 73 | 2024 | 25575 | 2.520 |
Why?
|
Cytokines | 36 | 2024 | 7317 | 2.020 |
Why?
|
Antimicrobial Cationic Peptides | 21 | 2018 | 362 | 2.010 |
Why?
|
Staphylococcus epidermidis | 8 | 2020 | 117 | 1.980 |
Why?
|
Vaccination | 20 | 2023 | 3256 | 1.960 |
Why?
|
Viral Vaccines | 7 | 2024 | 636 | 1.920 |
Why?
|
Toll-Like Receptor 7 | 7 | 2022 | 172 | 1.870 |
Why?
|
Fetal Blood | 13 | 2021 | 1317 | 1.830 |
Why?
|
Hepatitis B Vaccines | 4 | 2022 | 194 | 1.690 |
Why?
|
Imidazoles | 8 | 2017 | 1205 | 1.580 |
Why?
|
Pentoxifylline | 4 | 2020 | 55 | 1.580 |
Why?
|
Bell Palsy | 2 | 2021 | 42 | 1.510 |
Why?
|
Dendritic Cells | 10 | 2024 | 2723 | 1.490 |
Why?
|
Immune System | 8 | 2020 | 804 | 1.390 |
Why?
|
Immunization | 10 | 2022 | 1255 | 1.380 |
Why?
|
Quinolines | 5 | 2017 | 719 | 1.370 |
Why?
|
Respiratory Syncytial Virus, Human | 3 | 2022 | 137 | 1.310 |
Why?
|
Immunologic Memory | 7 | 2021 | 1348 | 1.190 |
Why?
|
Endotoxins | 5 | 2013 | 525 | 1.160 |
Why?
|
Respiratory Syncytial Virus Infections | 3 | 2022 | 324 | 1.130 |
Why?
|
Leukocytes | 8 | 2019 | 2039 | 1.070 |
Why?
|
Lipopolysaccharides | 10 | 2019 | 2211 | 1.050 |
Why?
|
Bacteremia | 7 | 2015 | 962 | 1.010 |
Why?
|
Infant, Premature | 8 | 2020 | 2041 | 0.980 |
Why?
|
Inflammasomes | 4 | 2018 | 493 | 0.960 |
Why?
|
Th1 Cells | 3 | 2024 | 1056 | 0.940 |
Why?
|
Toll-Like Receptor 2 | 5 | 2015 | 354 | 0.940 |
Why?
|
Blood Bactericidal Activity | 8 | 2005 | 126 | 0.930 |
Why?
|
Aging | 8 | 2018 | 8626 | 0.930 |
Why?
|
Adenosine | 4 | 2013 | 823 | 0.930 |
Why?
|
Adaptive Immunity | 5 | 2020 | 712 | 0.920 |
Why?
|
Immunization Schedule | 2 | 2020 | 221 | 0.850 |
Why?
|
Communicable Diseases | 3 | 2017 | 878 | 0.850 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2022 | 32 | 0.840 |
Why?
|
Alkaline Phosphatase | 2 | 2017 | 865 | 0.830 |
Why?
|
Shoulder Dislocation | 3 | 2020 | 122 | 0.820 |
Why?
|
Leukocytes, Mononuclear | 10 | 2023 | 1835 | 0.800 |
Why?
|
Gentamicins | 2 | 2020 | 253 | 0.790 |
Why?
|
Shoulder Joint | 9 | 2011 | 693 | 0.780 |
Why?
|
Tumor Necrosis Factor-alpha | 11 | 2023 | 4414 | 0.770 |
Why?
|
Inflammation Mediators | 5 | 2020 | 1889 | 0.760 |
Why?
|
Mandatory Programs | 1 | 2021 | 87 | 0.740 |
Why?
|
Anti-Inflammatory Agents | 4 | 2020 | 1788 | 0.710 |
Why?
|
Antibody Formation | 3 | 2022 | 1402 | 0.700 |
Why?
|
Mass Vaccination | 1 | 2021 | 105 | 0.700 |
Why?
|
Animals, Newborn | 13 | 2020 | 2723 | 0.690 |
Why?
|
Caspase 1 | 3 | 2018 | 223 | 0.680 |
Why?
|
Antigen-Presenting Cells | 4 | 2020 | 969 | 0.670 |
Why?
|
Vancomycin | 2 | 2020 | 500 | 0.660 |
Why?
|
Humans | 175 | 2024 | 742088 | 0.650 |
Why?
|
Microbial Viability | 1 | 2020 | 234 | 0.650 |
Why?
|
Staphylococcal Infections | 5 | 2020 | 1398 | 0.650 |
Why?
|
Legionnaires' Disease | 1 | 2018 | 48 | 0.640 |
Why?
|
Membrane Proteins | 14 | 2007 | 7873 | 0.640 |
Why?
|
Cathelicidins | 1 | 2018 | 80 | 0.630 |
Why?
|
Legionella pneumophila | 1 | 2018 | 46 | 0.630 |
Why?
|
RNA, Bacterial | 1 | 2020 | 391 | 0.620 |
Why?
|
B-Lymphocytes | 7 | 2024 | 4664 | 0.620 |
Why?
|
Adenosine Deaminase | 3 | 2021 | 241 | 0.620 |
Why?
|
Disease Susceptibility | 4 | 2017 | 1780 | 0.610 |
Why?
|
Bacterial Infections | 7 | 2013 | 1389 | 0.600 |
Why?
|
Shoulder Fractures | 2 | 2020 | 88 | 0.590 |
Why?
|
Mannose-Binding Lectin | 1 | 2018 | 150 | 0.590 |
Why?
|
Infant | 28 | 2022 | 35070 | 0.590 |
Why?
|
Lectins, C-Type | 3 | 2022 | 588 | 0.580 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2016 | 107 | 0.560 |
Why?
|
Oligodeoxyribonucleotides | 2 | 2016 | 708 | 0.560 |
Why?
|
Toll-Like Receptor 4 | 6 | 2012 | 561 | 0.560 |
Why?
|
Hepatitis | 1 | 2018 | 227 | 0.550 |
Why?
|
Acute-Phase Proteins | 4 | 2020 | 262 | 0.550 |
Why?
|
Neutrophils | 9 | 2015 | 3711 | 0.540 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2018 | 221 | 0.530 |
Why?
|
Immunity, Humoral | 2 | 2017 | 596 | 0.530 |
Why?
|
Vaccines, Conjugate | 1 | 2017 | 331 | 0.520 |
Why?
|
Gram-Negative Bacterial Infections | 2 | 2011 | 232 | 0.520 |
Why?
|
Staphylococcus | 2 | 2013 | 155 | 0.520 |
Why?
|
Sepsis | 6 | 2020 | 2589 | 0.510 |
Why?
|
5'-Nucleotidase | 2 | 2013 | 160 | 0.510 |
Why?
|
Immunity | 6 | 2023 | 1011 | 0.510 |
Why?
|
Trachea | 2 | 2012 | 1075 | 0.510 |
Why?
|
Animals | 62 | 2023 | 168561 | 0.500 |
Why?
|
B-Lymphocyte Subsets | 1 | 2016 | 246 | 0.500 |
Why?
|
Poliovirus Vaccine, Oral | 2 | 2016 | 28 | 0.500 |
Why?
|
Membrane Glycoproteins | 9 | 2013 | 3769 | 0.490 |
Why?
|
Receptors, Immunologic | 4 | 2019 | 1423 | 0.490 |
Why?
|
Hypersensitivity | 2 | 2021 | 1093 | 0.480 |
Why?
|
Anti-Infective Agents | 6 | 2018 | 971 | 0.470 |
Why?
|
Proteomics | 8 | 2023 | 3618 | 0.470 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 222 | 0.450 |
Why?
|
Organophosphorus Compounds | 1 | 2014 | 215 | 0.450 |
Why?
|
Pneumococcal Vaccines | 1 | 2017 | 390 | 0.450 |
Why?
|
Arthroplasty, Replacement | 4 | 2005 | 336 | 0.450 |
Why?
|
Inflammation | 9 | 2022 | 10578 | 0.440 |
Why?
|
Candida albicans | 3 | 2022 | 394 | 0.440 |
Why?
|
Antibodies, Viral | 9 | 2023 | 3164 | 0.430 |
Why?
|
Immunocompromised Host | 2 | 2011 | 847 | 0.430 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2020 | 2407 | 0.420 |
Why?
|
Clavicle | 2 | 2005 | 209 | 0.410 |
Why?
|
Nanoparticles | 2 | 2017 | 1902 | 0.410 |
Why?
|
Bacterial Vaccines | 2 | 2017 | 402 | 0.410 |
Why?
|
S100 Proteins | 1 | 2012 | 259 | 0.400 |
Why?
|
Interleukin-6 | 7 | 2023 | 3199 | 0.400 |
Why?
|
Receptors, Cell Surface | 5 | 2019 | 2867 | 0.400 |
Why?
|
Bone Marrow Diseases | 1 | 2013 | 230 | 0.400 |
Why?
|
Fibromyalgia | 1 | 2016 | 388 | 0.400 |
Why?
|
Proteome | 3 | 2022 | 1790 | 0.390 |
Why?
|
Endotoxemia | 3 | 2011 | 206 | 0.390 |
Why?
|
Immunologic Factors | 2 | 2013 | 1575 | 0.390 |
Why?
|
Th2 Cells | 1 | 2016 | 1049 | 0.380 |
Why?
|
Polymers | 2 | 2017 | 1618 | 0.380 |
Why?
|
Benzazepines | 1 | 2013 | 326 | 0.380 |
Why?
|
Arthroscopy | 4 | 2016 | 924 | 0.380 |
Why?
|
Hemostasis, Surgical | 1 | 2011 | 128 | 0.380 |
Why?
|
Adult | 47 | 2022 | 213712 | 0.370 |
Why?
|
United States Food and Drug Administration | 4 | 2022 | 1581 | 0.370 |
Why?
|
Alum Compounds | 3 | 2016 | 33 | 0.370 |
Why?
|
Immunity, Maternally-Acquired | 2 | 2010 | 118 | 0.370 |
Why?
|
Whooping Cough | 2 | 2022 | 82 | 0.370 |
Why?
|
Complement System Proteins | 3 | 2020 | 795 | 0.360 |
Why?
|
Accessory Nerve Diseases | 1 | 2009 | 2 | 0.350 |
Why?
|
RNA, Messenger | 11 | 2023 | 13029 | 0.350 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2022 | 4379 | 0.350 |
Why?
|
Fluoroquinolones | 1 | 2011 | 308 | 0.350 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2130 | 0.350 |
Why?
|
Escherichia coli | 5 | 2020 | 4214 | 0.350 |
Why?
|
Drug Design | 2 | 2013 | 1078 | 0.350 |
Why?
|
Homeostasis | 1 | 2020 | 3335 | 0.350 |
Why?
|
Rheumatic Diseases | 1 | 2016 | 590 | 0.350 |
Why?
|
Tuberculosis | 1 | 2022 | 1904 | 0.340 |
Why?
|
Communicable Disease Control | 3 | 2015 | 854 | 0.340 |
Why?
|
Tuberculosis Vaccines | 1 | 2009 | 49 | 0.340 |
Why?
|
Mucous Membrane | 3 | 2008 | 670 | 0.340 |
Why?
|
Chemokines | 5 | 2023 | 954 | 0.340 |
Why?
|
Defensins | 4 | 2002 | 35 | 0.330 |
Why?
|
Fatigue | 1 | 2016 | 1526 | 0.330 |
Why?
|
Cells, Cultured | 11 | 2020 | 19223 | 0.330 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2013 | 1213 | 0.320 |
Why?
|
Plasma | 3 | 2021 | 575 | 0.320 |
Why?
|
Cell Movement | 1 | 2020 | 5212 | 0.320 |
Why?
|
Brain Injuries | 3 | 2020 | 2024 | 0.320 |
Why?
|
Energy Metabolism | 1 | 2019 | 2896 | 0.320 |
Why?
|
AIDS Vaccines | 3 | 2019 | 938 | 0.320 |
Why?
|
Endothelium, Vascular | 1 | 2020 | 4455 | 0.320 |
Why?
|
Scapula | 1 | 2009 | 162 | 0.310 |
Why?
|
Recombinant Proteins | 8 | 2018 | 6608 | 0.310 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2021 | 2026 | 0.310 |
Why?
|
Paralysis | 1 | 2009 | 249 | 0.300 |
Why?
|
Age Factors | 14 | 2021 | 18355 | 0.300 |
Why?
|
Ventilators, Mechanical | 1 | 2009 | 292 | 0.290 |
Why?
|
Receptor, Adenosine A3 | 1 | 2006 | 4 | 0.290 |
Why?
|
Vaccines, DNA | 1 | 2008 | 305 | 0.290 |
Why?
|
Blood Loss, Surgical | 1 | 2011 | 656 | 0.290 |
Why?
|
Attitude | 2 | 2022 | 772 | 0.290 |
Why?
|
Virus Diseases | 2 | 2013 | 710 | 0.290 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3770 | 0.280 |
Why?
|
Mice | 30 | 2023 | 81045 | 0.280 |
Why?
|
Hypoxia-Ischemia, Brain | 2 | 2020 | 326 | 0.280 |
Why?
|
Colony Count, Microbial | 2 | 2018 | 331 | 0.280 |
Why?
|
Female | 59 | 2024 | 379592 | 0.260 |
Why?
|
Signal Transduction | 14 | 2020 | 23387 | 0.260 |
Why?
|
Immunization Programs | 4 | 2019 | 259 | 0.260 |
Why?
|
Anti-Bacterial Agents | 9 | 2020 | 7153 | 0.260 |
Why?
|
Aluminum Hydroxide | 2 | 2022 | 58 | 0.260 |
Why?
|
Pseudarthrosis | 1 | 2005 | 59 | 0.260 |
Why?
|
Cyclic AMP | 3 | 2019 | 1470 | 0.260 |
Why?
|
Chemokine CCL2 | 2 | 2020 | 617 | 0.260 |
Why?
|
Phosphates | 2 | 2020 | 786 | 0.250 |
Why?
|
Babesiosis | 1 | 2006 | 90 | 0.250 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2013 | 5425 | 0.250 |
Why?
|
Lipid A | 2 | 2016 | 67 | 0.250 |
Why?
|
Mice, Inbred C57BL | 12 | 2022 | 21821 | 0.250 |
Why?
|
Docosahexaenoic Acids | 1 | 2011 | 875 | 0.250 |
Why?
|
Aminoquinolines | 1 | 2004 | 109 | 0.240 |
Why?
|
Radiation Injuries | 1 | 2011 | 1178 | 0.240 |
Why?
|
Immunomodulation | 3 | 2021 | 540 | 0.240 |
Why?
|
Flagellin | 2 | 2020 | 125 | 0.240 |
Why?
|
Models, Biological | 1 | 2020 | 9581 | 0.240 |
Why?
|
Cross-Priming | 1 | 2024 | 82 | 0.230 |
Why?
|
Chickenpox Vaccine | 1 | 2003 | 79 | 0.230 |
Why?
|
Pain | 3 | 2022 | 4961 | 0.230 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2009 | 700 | 0.230 |
Why?
|
Muscle, Skeletal | 2 | 2009 | 4933 | 0.230 |
Why?
|
Infant, Premature, Diseases | 2 | 2007 | 706 | 0.230 |
Why?
|
Male | 46 | 2022 | 349538 | 0.230 |
Why?
|
Immunity, Cellular | 4 | 2017 | 1606 | 0.230 |
Why?
|
Mice, Inbred BALB C | 5 | 2022 | 6382 | 0.230 |
Why?
|
Pertussis Vaccine | 2 | 2022 | 34 | 0.220 |
Why?
|
Lipoproteins | 2 | 2006 | 876 | 0.220 |
Why?
|
Physical Examination | 1 | 2009 | 1239 | 0.220 |
Why?
|
Biomedical Research | 1 | 2018 | 3306 | 0.220 |
Why?
|
Escherichia coli Infections | 2 | 2020 | 532 | 0.220 |
Why?
|
HIV Infections | 7 | 2023 | 16678 | 0.210 |
Why?
|
Herpesvirus 3, Human | 1 | 2003 | 204 | 0.210 |
Why?
|
Pregnancy | 13 | 2023 | 29087 | 0.210 |
Why?
|
Hemagglutinins | 1 | 2022 | 117 | 0.210 |
Why?
|
Viral Fusion Proteins | 1 | 2022 | 95 | 0.210 |
Why?
|
NF-kappa B | 4 | 2018 | 2500 | 0.210 |
Why?
|
Body Fluids | 1 | 2024 | 319 | 0.210 |
Why?
|
Mannans | 1 | 2022 | 63 | 0.200 |
Why?
|
Streptococcus agalactiae | 1 | 2003 | 375 | 0.200 |
Why?
|
Immune Tolerance | 3 | 2012 | 2257 | 0.200 |
Why?
|
Exercise Therapy | 1 | 2008 | 904 | 0.200 |
Why?
|
Systems Biology | 3 | 2022 | 469 | 0.200 |
Why?
|
Proteins | 4 | 2023 | 6096 | 0.200 |
Why?
|
Macrophages | 4 | 2022 | 5655 | 0.200 |
Why?
|
Bone Marrow | 1 | 2011 | 2941 | 0.200 |
Why?
|
Respiration, Artificial | 1 | 2012 | 2566 | 0.200 |
Why?
|
Gram-Negative Bacteria | 2 | 2000 | 270 | 0.200 |
Why?
|
Antigens, Viral | 2 | 2022 | 1034 | 0.200 |
Why?
|
Up-Regulation | 4 | 2020 | 4211 | 0.200 |
Why?
|
Herpes Zoster | 1 | 2003 | 264 | 0.190 |
Why?
|
Gambia | 3 | 2021 | 98 | 0.190 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2002 | 174 | 0.190 |
Why?
|
Gestational Age | 3 | 2019 | 3490 | 0.190 |
Why?
|
Humerus | 2 | 2017 | 265 | 0.190 |
Why?
|
Epithelial Cells | 5 | 2011 | 3678 | 0.190 |
Why?
|
Acyclovir | 1 | 2021 | 272 | 0.190 |
Why?
|
Public-Private Sector Partnerships | 1 | 2021 | 120 | 0.180 |
Why?
|
HIV-1 | 5 | 2022 | 6934 | 0.180 |
Why?
|
Bulgaria | 1 | 2020 | 25 | 0.180 |
Why?
|
Toll-Like Receptor 5 | 1 | 2020 | 39 | 0.180 |
Why?
|
Toll-Like Receptor 9 | 2 | 2024 | 212 | 0.180 |
Why?
|
Vaccines, Attenuated | 2 | 2016 | 341 | 0.180 |
Why?
|
Prosthesis Design | 4 | 2017 | 2110 | 0.180 |
Why?
|
Phagocytosis | 5 | 2012 | 1538 | 0.180 |
Why?
|
Bottle Feeding | 1 | 2019 | 66 | 0.180 |
Why?
|
Osteoarthritis | 2 | 2005 | 1034 | 0.180 |
Why?
|
Chromatography, Liquid | 3 | 2022 | 977 | 0.170 |
Why?
|
Fentanyl | 1 | 2022 | 410 | 0.170 |
Why?
|
Fetus | 1 | 2007 | 1879 | 0.170 |
Why?
|
Lymphocyte Activation | 4 | 2021 | 5519 | 0.170 |
Why?
|
Mycobacterium bovis | 1 | 2020 | 150 | 0.170 |
Why?
|
Candidiasis | 1 | 2002 | 365 | 0.170 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2021 | 1675 | 0.170 |
Why?
|
Congresses as Topic | 3 | 2019 | 764 | 0.170 |
Why?
|
Education | 2 | 2019 | 543 | 0.170 |
Why?
|
Antibodies, Neutralizing | 4 | 2023 | 1970 | 0.170 |
Why?
|
Killer Cells, Natural | 2 | 2009 | 2133 | 0.170 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 2 | 2010 | 78 | 0.170 |
Why?
|
Virulence Factors, Bordetella | 1 | 2018 | 156 | 0.170 |
Why?
|
Interleukin-10 | 2 | 2017 | 1200 | 0.170 |
Why?
|
United States | 9 | 2022 | 69693 | 0.170 |
Why?
|
MAP Kinase Signaling System | 1 | 2006 | 1525 | 0.170 |
Why?
|
Immunophenotyping | 2 | 2020 | 1866 | 0.160 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2018 | 44 | 0.160 |
Why?
|
Chorioamnionitis | 1 | 2019 | 155 | 0.160 |
Why?
|
Fimbriae Proteins | 1 | 2018 | 134 | 0.160 |
Why?
|
Carrier Proteins | 3 | 2013 | 5019 | 0.160 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2012 | 571 | 0.160 |
Why?
|
Macaca mulatta | 2 | 2017 | 2378 | 0.160 |
Why?
|
Immunologic Deficiency Syndromes | 3 | 2008 | 546 | 0.160 |
Why?
|
Interdisciplinary Studies | 1 | 2018 | 89 | 0.160 |
Why?
|
Child Development | 2 | 2020 | 2222 | 0.160 |
Why?
|
Infant Formula | 1 | 2019 | 199 | 0.160 |
Why?
|
Blood Cells | 2 | 2015 | 309 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2018 | 1284 | 0.150 |
Why?
|
Fracture Fixation, Internal | 2 | 2020 | 916 | 0.150 |
Why?
|
Denmark | 1 | 2020 | 736 | 0.150 |
Why?
|
Tissue Culture Techniques | 1 | 2018 | 291 | 0.150 |
Why?
|
RNA | 1 | 2007 | 2747 | 0.150 |
Why?
|
Rosaniline Dyes | 1 | 2017 | 51 | 0.150 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2004 | 778 | 0.150 |
Why?
|
Term Birth | 1 | 2018 | 135 | 0.150 |
Why?
|
Child | 13 | 2023 | 77478 | 0.150 |
Why?
|
Premature Birth | 2 | 2020 | 1713 | 0.150 |
Why?
|
Immunoglobulins | 1 | 2020 | 880 | 0.150 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4438 | 0.150 |
Why?
|
Histocytochemistry | 1 | 2018 | 718 | 0.150 |
Why?
|
Cell Wall | 1 | 2020 | 422 | 0.140 |
Why?
|
Metabolomics | 3 | 2020 | 1467 | 0.140 |
Why?
|
Azithromycin | 1 | 2018 | 195 | 0.140 |
Why?
|
Vulnerable Populations | 1 | 2022 | 685 | 0.140 |
Why?
|
Salmonella | 1 | 2017 | 129 | 0.140 |
Why?
|
Nutritive Value | 1 | 2019 | 339 | 0.140 |
Why?
|
Respiratory Mucosa | 1 | 2020 | 427 | 0.140 |
Why?
|
Poliovirus Vaccine, Inactivated | 1 | 2016 | 24 | 0.140 |
Why?
|
Drug Synergism | 2 | 2018 | 1791 | 0.140 |
Why?
|
Lactoferrin | 2 | 2013 | 97 | 0.140 |
Why?
|
Enzyme Assays | 1 | 2017 | 111 | 0.140 |
Why?
|
HIV Seropositivity | 1 | 2022 | 970 | 0.140 |
Why?
|
Israel | 2 | 2016 | 795 | 0.140 |
Why?
|
Adolescent | 16 | 2024 | 85649 | 0.140 |
Why?
|
Malaria Vaccines | 1 | 2017 | 158 | 0.140 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2016 | 130 | 0.140 |
Why?
|
Ectodermal Dysplasia | 2 | 2008 | 103 | 0.140 |
Why?
|
Vaccines, Inactivated | 1 | 2016 | 184 | 0.130 |
Why?
|
Fungal Proteins | 1 | 2020 | 912 | 0.130 |
Why?
|
Androgens | 1 | 2023 | 1271 | 0.130 |
Why?
|
HIV Antibodies | 2 | 2019 | 1320 | 0.130 |
Why?
|
Biomimetics | 1 | 2017 | 172 | 0.130 |
Why?
|
Range of Motion, Articular | 4 | 2008 | 1577 | 0.130 |
Why?
|
Japan | 1 | 2020 | 1360 | 0.130 |
Why?
|
Interleukin-12 | 2 | 2022 | 579 | 0.130 |
Why?
|
T-Lymphocytes | 4 | 2022 | 10163 | 0.130 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2015 | 55 | 0.130 |
Why?
|
Klebsiella pneumoniae | 1 | 2017 | 246 | 0.130 |
Why?
|
Lipoxins | 2 | 2011 | 411 | 0.130 |
Why?
|
Chemokine CXCL1 | 1 | 2015 | 101 | 0.130 |
Why?
|
Poliomyelitis | 1 | 2016 | 103 | 0.130 |
Why?
|
Milk, Human | 1 | 2019 | 490 | 0.130 |
Why?
|
HEK293 Cells | 2 | 2015 | 4200 | 0.130 |
Why?
|
Myocarditis | 1 | 2022 | 770 | 0.130 |
Why?
|
Quality of Life | 1 | 2016 | 12730 | 0.120 |
Why?
|
Flow Cytometry | 4 | 2013 | 5975 | 0.120 |
Why?
|
Aged | 17 | 2022 | 162944 | 0.120 |
Why?
|
Immunoglobulin Class Switching | 1 | 2016 | 291 | 0.120 |
Why?
|
Systems Analysis | 1 | 2015 | 171 | 0.120 |
Why?
|
Lung | 3 | 2022 | 9826 | 0.120 |
Why?
|
Bone Marrow Cells | 1 | 2002 | 2513 | 0.120 |
Why?
|
Still's Disease, Adult-Onset | 1 | 2014 | 19 | 0.120 |
Why?
|
Cell Adhesion Molecules | 2 | 2011 | 1599 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 15494 | 0.120 |
Why?
|
Bone Marrow Transplantation | 1 | 2002 | 2763 | 0.120 |
Why?
|
Brain | 3 | 2020 | 26343 | 0.120 |
Why?
|
Enteral Nutrition | 1 | 2019 | 763 | 0.120 |
Why?
|
Cell Adhesion | 1 | 2020 | 3139 | 0.120 |
Why?
|
Analysis of Variance | 2 | 2013 | 6365 | 0.120 |
Why?
|
Radiography | 4 | 2013 | 7010 | 0.110 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1887 | 0.110 |
Why?
|
India | 1 | 2020 | 2187 | 0.110 |
Why?
|
Influenza Vaccines | 1 | 2021 | 733 | 0.110 |
Why?
|
Mass Spectrometry | 2 | 2022 | 2203 | 0.110 |
Why?
|
Pancreatectomy | 1 | 2018 | 802 | 0.110 |
Why?
|
Interleukin-1beta | 2 | 2017 | 972 | 0.110 |
Why?
|
Limulus Test | 1 | 2012 | 19 | 0.110 |
Why?
|
Disease Transmission, Infectious | 1 | 2018 | 546 | 0.110 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2015 | 341 | 0.110 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2018 | 744 | 0.110 |
Why?
|
Antigens, Bacterial | 1 | 2018 | 1170 | 0.110 |
Why?
|
Inosine | 1 | 2013 | 133 | 0.110 |
Why?
|
Treatment Outcome | 10 | 2020 | 62966 | 0.110 |
Why?
|
Microscopy | 1 | 2018 | 903 | 0.110 |
Why?
|
Caspase 3 | 1 | 2015 | 759 | 0.110 |
Why?
|
Isoenzymes | 1 | 2017 | 1725 | 0.100 |
Why?
|
Vaccines, Subunit | 1 | 2012 | 168 | 0.100 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 697 | 0.100 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6483 | 0.100 |
Why?
|
Enzyme Activation | 1 | 2018 | 3701 | 0.100 |
Why?
|
Activities of Daily Living | 2 | 2016 | 2414 | 0.100 |
Why?
|
C-Reactive Protein | 1 | 2003 | 3766 | 0.100 |
Why?
|
Disease Models, Animal | 5 | 2023 | 18006 | 0.100 |
Why?
|
Immunoglobulin M | 1 | 2016 | 1538 | 0.100 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2015 | 340 | 0.100 |
Why?
|
Mice, SCID | 1 | 2017 | 2715 | 0.100 |
Why?
|
Interleukins | 1 | 2016 | 791 | 0.100 |
Why?
|
Vaccines, Acellular | 2 | 2022 | 11 | 0.100 |
Why?
|
Spleen | 2 | 2015 | 2359 | 0.100 |
Why?
|
Lymphocyte Antigen 96 | 1 | 2010 | 19 | 0.100 |
Why?
|
Breast Feeding | 1 | 2019 | 1339 | 0.100 |
Why?
|
Drug Delivery Systems | 2 | 2020 | 2217 | 0.100 |
Why?
|
Severity of Illness Index | 4 | 2022 | 15530 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 3862 | 0.100 |
Why?
|
Epigenesis, Genetic | 2 | 2015 | 3639 | 0.100 |
Why?
|
Genetic Testing | 1 | 2004 | 3439 | 0.100 |
Why?
|
Young Adult | 7 | 2024 | 56350 | 0.100 |
Why?
|
Whole-Body Irradiation | 1 | 2011 | 449 | 0.100 |
Why?
|
Dexamethasone | 1 | 2018 | 1949 | 0.090 |
Why?
|
Blood Cell Count | 1 | 2011 | 402 | 0.090 |
Why?
|
Fractures, Bone | 1 | 2003 | 1945 | 0.090 |
Why?
|
Bacteriolysis | 1 | 2010 | 51 | 0.090 |
Why?
|
Lipopeptides | 2 | 2011 | 75 | 0.090 |
Why?
|
Gene Expression Regulation | 4 | 2018 | 12071 | 0.090 |
Why?
|
Cell Proliferation | 4 | 2016 | 10472 | 0.090 |
Why?
|
Adenosine Triphosphate | 1 | 2017 | 2024 | 0.090 |
Why?
|
Receptors, IgG | 1 | 2013 | 582 | 0.090 |
Why?
|
Injections, Intravenous | 1 | 2012 | 1420 | 0.090 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 1449 | 0.090 |
Why?
|
I-kappa B Kinase | 2 | 2008 | 251 | 0.090 |
Why?
|
Thoracic Nerves | 1 | 2009 | 19 | 0.090 |
Why?
|
Iatrogenic Disease | 1 | 2013 | 545 | 0.090 |
Why?
|
Insulin Resistance | 1 | 2023 | 3861 | 0.090 |
Why?
|
Organ Size | 2 | 2011 | 2253 | 0.090 |
Why?
|
Phospholipids | 2 | 2008 | 781 | 0.090 |
Why?
|
Middle Aged | 14 | 2020 | 213127 | 0.090 |
Why?
|
Liver | 3 | 2015 | 7470 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2016 | 2372 | 0.090 |
Why?
|
Hip Joint | 1 | 2016 | 1002 | 0.090 |
Why?
|
Phenotype | 3 | 2024 | 16331 | 0.090 |
Why?
|
Vaccines, Synthetic | 2 | 2022 | 633 | 0.080 |
Why?
|
Patient Satisfaction | 2 | 2016 | 3391 | 0.080 |
Why?
|
Mice, Knockout | 3 | 2015 | 14554 | 0.080 |
Why?
|
Blotting, Western | 2 | 2011 | 5180 | 0.080 |
Why?
|
Ablation Techniques | 1 | 2011 | 249 | 0.080 |
Why?
|
Ligands | 3 | 2022 | 3293 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2276 | 0.080 |
Why?
|
Antigen Presentation | 1 | 2014 | 1284 | 0.080 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6171 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2004 | 3695 | 0.080 |
Why?
|
Crassostrea | 1 | 2007 | 1 | 0.080 |
Why?
|
Apyrase | 1 | 2011 | 364 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 867 | 0.080 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2009 | 1368 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 9941 | 0.080 |
Why?
|
Oligopeptides | 2 | 2019 | 1176 | 0.080 |
Why?
|
Sampling Studies | 1 | 2009 | 623 | 0.080 |
Why?
|
Blood | 1 | 2010 | 598 | 0.080 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 2062 | 0.080 |
Why?
|
Hematopoiesis | 2 | 2020 | 2066 | 0.080 |
Why?
|
Organ Specificity | 1 | 2012 | 2003 | 0.080 |
Why?
|
Child, Preschool | 7 | 2011 | 40955 | 0.070 |
Why?
|
Genetic Diseases, X-Linked | 2 | 2008 | 370 | 0.070 |
Why?
|
Adenosine A3 Receptor Antagonists | 1 | 2006 | 2 | 0.070 |
Why?
|
Rupture | 1 | 2008 | 430 | 0.070 |
Why?
|
Antigens, CD | 2 | 2011 | 4024 | 0.070 |
Why?
|
Bursa, Synovial | 1 | 2006 | 24 | 0.070 |
Why?
|
Shoulder Impingement Syndrome | 1 | 2006 | 33 | 0.070 |
Why?
|
Macrophage-1 Antigen | 2 | 2006 | 290 | 0.070 |
Why?
|
Time Factors | 4 | 2021 | 40054 | 0.070 |
Why?
|
Neutropenia | 1 | 2011 | 891 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2008 | 17400 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2012 | 3617 | 0.070 |
Why?
|
Babesia | 1 | 2006 | 26 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10392 | 0.070 |
Why?
|
Receptors, Virus | 1 | 2009 | 648 | 0.070 |
Why?
|
Biopsy | 1 | 2018 | 6756 | 0.070 |
Why?
|
Neurologic Examination | 1 | 2009 | 931 | 0.070 |
Why?
|
Thiazoles | 1 | 2013 | 1484 | 0.070 |
Why?
|
Joint Instability | 2 | 2004 | 792 | 0.070 |
Why?
|
Polydeoxyribonucleotides | 1 | 2006 | 127 | 0.070 |
Why?
|
I-kappa B Proteins | 1 | 2006 | 225 | 0.070 |
Why?
|
Rotator Cuff | 1 | 2008 | 324 | 0.070 |
Why?
|
Cohort Studies | 4 | 2021 | 40450 | 0.070 |
Why?
|
Boston | 1 | 2018 | 9305 | 0.060 |
Why?
|
Models, Immunological | 1 | 2007 | 527 | 0.060 |
Why?
|
Peptides | 3 | 2009 | 4392 | 0.060 |
Why?
|
Interferon Inducers | 1 | 2004 | 25 | 0.060 |
Why?
|
Myeloid Cells | 2 | 2007 | 804 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3731 | 0.060 |
Why?
|
Lymphoid Tissue | 1 | 2006 | 455 | 0.060 |
Why?
|
Lymphocyte Subsets | 2 | 2009 | 315 | 0.060 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2699 | 0.060 |
Why?
|
Asthma | 1 | 2023 | 5955 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.060 |
Why?
|
Pronation | 1 | 2004 | 51 | 0.060 |
Why?
|
Muscle Strength | 1 | 2008 | 586 | 0.060 |
Why?
|
Supination | 1 | 2004 | 68 | 0.060 |
Why?
|
Integrin alphaXbeta2 | 1 | 2003 | 29 | 0.060 |
Why?
|
Antirheumatic Agents | 1 | 2014 | 1335 | 0.060 |
Why?
|
Electromyography | 1 | 2009 | 1391 | 0.060 |
Why?
|
Phosphorylation | 2 | 2006 | 8436 | 0.060 |
Why?
|
Complement Factor B | 1 | 2003 | 72 | 0.060 |
Why?
|
Safety | 1 | 2009 | 1185 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4751 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15056 | 0.060 |
Why?
|
Lipocalins | 1 | 2004 | 170 | 0.060 |
Why?
|
Poverty | 1 | 2015 | 2646 | 0.060 |
Why?
|
Muscle Contraction | 1 | 2008 | 1241 | 0.060 |
Why?
|
Macrophage Activation | 1 | 2006 | 558 | 0.060 |
Why?
|
Host-Pathogen Interactions | 3 | 2020 | 1477 | 0.060 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2885 | 0.060 |
Why?
|
Dinoprostone | 2 | 2018 | 600 | 0.050 |
Why?
|
Adjuvants, Pharmaceutic | 1 | 2022 | 50 | 0.050 |
Why?
|
Uterus | 1 | 2007 | 710 | 0.050 |
Why?
|
Computational Biology | 2 | 2019 | 3518 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 24913 | 0.050 |
Why?
|
Equipment Design | 1 | 2011 | 3582 | 0.050 |
Why?
|
Intestinal Mucosa | 2 | 2011 | 3038 | 0.050 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2003 | 768 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2012 | 5062 | 0.050 |
Why?
|
Transcription Factor RelB | 1 | 2022 | 29 | 0.050 |
Why?
|
Serum | 1 | 2003 | 212 | 0.050 |
Why?
|
Bone Cements | 1 | 2004 | 325 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4147 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3920 | 0.050 |
Why?
|
Weight Gain | 1 | 2012 | 2282 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2011 | 2440 | 0.050 |
Why?
|
Joint Prosthesis | 1 | 2004 | 257 | 0.050 |
Why?
|
Rotation | 1 | 2004 | 523 | 0.050 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2022 | 986 | 0.050 |
Why?
|
Cell Extracts | 1 | 2002 | 138 | 0.050 |
Why?
|
Pneumococcal Infections | 1 | 2006 | 496 | 0.050 |
Why?
|
Anti-Retroviral Agents | 2 | 2023 | 1712 | 0.050 |
Why?
|
Amphotericin B | 1 | 2002 | 137 | 0.050 |
Why?
|
Antibodies | 1 | 2010 | 2459 | 0.050 |
Why?
|
Complement C3 | 1 | 2003 | 460 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2009 | 1366 | 0.050 |
Why?
|
Ligaments, Articular | 1 | 2004 | 298 | 0.050 |
Why?
|
Interleukin-13 | 1 | 2023 | 389 | 0.050 |
Why?
|
Plant Physiological Phenomena | 1 | 2000 | 16 | 0.050 |
Why?
|
beta-Glucans | 1 | 2022 | 123 | 0.050 |
Why?
|
Anura | 1 | 2000 | 85 | 0.050 |
Why?
|
Mutation | 5 | 2011 | 29717 | 0.050 |
Why?
|
Vero Cells | 1 | 2022 | 485 | 0.050 |
Why?
|
Humeral Head | 1 | 2020 | 41 | 0.050 |
Why?
|
Animal Experimentation | 1 | 2020 | 45 | 0.050 |
Why?
|
Pediatrics | 1 | 2015 | 3462 | 0.050 |
Why?
|
Sutures | 1 | 2003 | 298 | 0.050 |
Why?
|
Colitis | 1 | 2008 | 1149 | 0.050 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2002 | 319 | 0.050 |
Why?
|
Solubility | 1 | 2022 | 1083 | 0.050 |
Why?
|
Clinical Trials as Topic | 3 | 2019 | 7901 | 0.050 |
Why?
|
Oncogene Proteins | 1 | 2004 | 749 | 0.040 |
Why?
|
Genetic Diseases, Inborn | 1 | 2005 | 587 | 0.040 |
Why?
|
Toll-Like Receptor 3 | 2 | 2012 | 91 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2015 | 11470 | 0.040 |
Why?
|
Protein Conformation | 2 | 2009 | 4013 | 0.040 |
Why?
|
Arthroplasty | 1 | 2002 | 305 | 0.040 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2723 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2022 | 1094 | 0.040 |
Why?
|
Reoperation | 3 | 2004 | 4200 | 0.040 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2020 | 215 | 0.040 |
Why?
|
Papua New Guinea | 1 | 2019 | 42 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 11695 | 0.040 |
Why?
|
Accidents, Traffic | 1 | 2005 | 819 | 0.040 |
Why?
|
Lymph Nodes | 2 | 2022 | 3465 | 0.040 |
Why?
|
Paranasal Sinuses | 1 | 2022 | 249 | 0.040 |
Why?
|
Diglycerides | 1 | 2019 | 176 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2002 | 627 | 0.040 |
Why?
|
HIV Seronegativity | 1 | 2020 | 211 | 0.040 |
Why?
|
Bordetella pertussis | 1 | 2018 | 43 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 29010 | 0.040 |
Why?
|
Belgium | 1 | 2018 | 103 | 0.040 |
Why?
|
Genotype | 1 | 2013 | 12946 | 0.040 |
Why?
|
Administration, Topical | 1 | 2000 | 688 | 0.040 |
Why?
|
Administration, Intranasal | 1 | 2020 | 446 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10248 | 0.040 |
Why?
|
Aged, 80 and over | 5 | 2008 | 57683 | 0.040 |
Why?
|
Prosthesis Failure | 1 | 2004 | 1203 | 0.040 |
Why?
|
Troponin | 1 | 2022 | 524 | 0.040 |
Why?
|
Protein Subunits | 1 | 2022 | 960 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7721 | 0.040 |
Why?
|
Prevalence | 2 | 2013 | 15194 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 704 | 0.040 |
Why?
|
Antibodies, Bacterial | 2 | 2018 | 1469 | 0.040 |
Why?
|
Aerosols | 1 | 2000 | 623 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5385 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 1 | 2006 | 1989 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2002 | 839 | 0.040 |
Why?
|
Placenta | 1 | 2007 | 1694 | 0.040 |
Why?
|
Pandemics | 3 | 2022 | 8328 | 0.040 |
Why?
|
HLA Antigens | 1 | 2003 | 1382 | 0.040 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 58 | 0.040 |
Why?
|
Antigens | 2 | 2016 | 1462 | 0.040 |
Why?
|
Cell Membrane | 2 | 2004 | 3744 | 0.040 |
Why?
|
Suture Techniques | 1 | 2002 | 797 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2006 | 2524 | 0.040 |
Why?
|
High-Throughput Screening Assays | 1 | 2023 | 944 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2020 | 647 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2023 | 900 | 0.040 |
Why?
|
Rabbits | 2 | 1994 | 4886 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2002 | 1849 | 0.040 |
Why?
|
DNA, Complementary | 2 | 2007 | 2049 | 0.040 |
Why?
|
Creatinine | 1 | 2022 | 1916 | 0.040 |
Why?
|
DNA, Viral | 1 | 2003 | 2224 | 0.040 |
Why?
|
Lipids | 2 | 2012 | 3302 | 0.040 |
Why?
|
Disease Progression | 2 | 2024 | 13256 | 0.040 |
Why?
|
Benchmarking | 1 | 2023 | 1038 | 0.040 |
Why?
|
Immunity, Mucosal | 1 | 2020 | 491 | 0.040 |
Why?
|
Prospective Studies | 4 | 2022 | 53187 | 0.040 |
Why?
|
Bacterial Proteins | 2 | 2006 | 3843 | 0.030 |
Why?
|
Muramidase | 1 | 1996 | 174 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2007 | 2837 | 0.030 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2018 | 404 | 0.030 |
Why?
|
Phospholipases A | 1 | 1996 | 216 | 0.030 |
Why?
|
Interferon Type I | 2 | 2010 | 542 | 0.030 |
Why?
|
Bone Transplantation | 1 | 2020 | 907 | 0.030 |
Why?
|
Protein Binding | 3 | 2019 | 9387 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2023 | 13921 | 0.030 |
Why?
|
Escherichia coli Proteins | 1 | 2002 | 1052 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2569 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1600 | 0.030 |
Why?
|
France | 1 | 2016 | 517 | 0.030 |
Why?
|
Regeneration | 1 | 2004 | 1485 | 0.030 |
Why?
|
Reference Values | 1 | 2002 | 4982 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2022 | 9410 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1847 | 0.030 |
Why?
|
Pain Measurement | 1 | 2004 | 3418 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15244 | 0.030 |
Why?
|
Cell Separation | 1 | 1999 | 1749 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14720 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2899 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2013 | 7645 | 0.030 |
Why?
|
Patient Positioning | 1 | 2016 | 322 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2002 | 3199 | 0.030 |
Why?
|
Drug Substitution | 1 | 2016 | 281 | 0.030 |
Why?
|
Workflow | 1 | 2018 | 846 | 0.030 |
Why?
|
Phylogeny | 1 | 2000 | 2797 | 0.030 |
Why?
|
Caco-2 Cells | 2 | 2005 | 387 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1038 | 0.030 |
Why?
|
Models, Molecular | 1 | 2003 | 5454 | 0.030 |
Why?
|
Viral Load | 1 | 2022 | 3292 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2123 | 0.030 |
Why?
|
Measles Vaccine | 1 | 2013 | 76 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1837 | 0.030 |
Why?
|
Drug Carriers | 1 | 2017 | 692 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 2007 | 13814 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2018 | 1157 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2004 | 4553 | 0.030 |
Why?
|
Patient Selection | 1 | 2004 | 4214 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2020 | 1872 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2007 | 18112 | 0.020 |
Why?
|
Pancreatitis | 1 | 2018 | 1090 | 0.020 |
Why?
|
Cross Infection | 1 | 2020 | 1413 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2013 | 77098 | 0.020 |
Why?
|
Carbohydrates | 1 | 2012 | 391 | 0.020 |
Why?
|
Mammals | 1 | 1996 | 1135 | 0.020 |
Why?
|
Molecular Weight | 1 | 1993 | 2255 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1801 | 0.020 |
Why?
|
Interleukin-2 Receptor beta Subunit | 1 | 2009 | 24 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 21596 | 0.020 |
Why?
|
Receptors, Interleukin-1 | 1 | 2010 | 261 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2002 | 2978 | 0.020 |
Why?
|
Purines | 1 | 2012 | 593 | 0.020 |
Why?
|
STAT1 Transcription Factor | 1 | 2010 | 320 | 0.020 |
Why?
|
Clusterin | 1 | 2009 | 72 | 0.020 |
Why?
|
Cell Line | 3 | 2010 | 15994 | 0.020 |
Why?
|
Transfection | 2 | 2010 | 5892 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1567 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1993 | 1574 | 0.020 |
Why?
|
Granulocytes | 1 | 2010 | 546 | 0.020 |
Why?
|
Ostreidae | 1 | 2007 | 3 | 0.020 |
Why?
|
Risk Factors | 2 | 2013 | 72145 | 0.020 |
Why?
|
Invertebrates | 1 | 2007 | 50 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 3913 | 0.020 |
Why?
|
Coagulase | 1 | 2007 | 54 | 0.020 |
Why?
|
Down-Regulation | 2 | 2006 | 3001 | 0.020 |
Why?
|
Expressed Sequence Tags | 1 | 2007 | 255 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2009 | 474 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2008 | 964 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1993 | 4322 | 0.020 |
Why?
|
K562 Cells | 1 | 2008 | 632 | 0.020 |
Why?
|
Streptolysins | 1 | 2006 | 55 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2018 | 4554 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2000 | 12017 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2009 | 689 | 0.020 |
Why?
|
Sp Transcription Factors | 1 | 2005 | 2 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3527 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3667 | 0.020 |
Why?
|
Peritonitis | 1 | 2008 | 365 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2007 | 590 | 0.020 |
Why?
|
Phagocytes | 1 | 2007 | 297 | 0.020 |
Why?
|
Swine | 1 | 2015 | 5934 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6249 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2009 | 2085 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1993 | 2126 | 0.020 |
Why?
|
Diet | 1 | 2023 | 7923 | 0.020 |
Why?
|
Molecular Chaperones | 1 | 2009 | 742 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2010 | 1871 | 0.020 |
Why?
|
Hot Temperature | 1 | 2010 | 1355 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 286 | 0.020 |
Why?
|
Siblings | 1 | 2008 | 854 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2010 | 1782 | 0.010 |
Why?
|
Ethanol | 1 | 2010 | 1337 | 0.010 |
Why?
|
Binding Sites | 1 | 1993 | 6115 | 0.010 |
Why?
|
Decidua | 1 | 2003 | 86 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5692 | 0.010 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2008 | 609 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2007 | 2257 | 0.010 |
Why?
|
Microglia | 1 | 2011 | 1261 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8425 | 0.010 |
Why?
|
Apoptosis | 2 | 2011 | 9715 | 0.010 |
Why?
|
Acromioclavicular Joint | 1 | 2004 | 75 | 0.010 |
Why?
|
Mice, Nude | 1 | 2009 | 3689 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10232 | 0.010 |
Why?
|
Allergens | 1 | 2009 | 1314 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2011 | 1704 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2003 | 1159 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2003 | 898 | 0.010 |
Why?
|
Learning | 1 | 2011 | 1705 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 35342 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 2006 | 712 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12705 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2003 | 1456 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2008 | 4771 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13853 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 1723 | 0.010 |
Why?
|
Salmonella typhimurium | 1 | 2002 | 351 | 0.010 |
Why?
|
Pedigree | 1 | 2007 | 4646 | 0.010 |
Why?
|
Cysteine | 1 | 2003 | 873 | 0.010 |
Why?
|
Hippocampus | 1 | 2011 | 3661 | 0.010 |
Why?
|
Vitamin D | 1 | 2012 | 3211 | 0.010 |
Why?
|
Protein Transport | 1 | 2002 | 1988 | 0.010 |
Why?
|
Treatment Failure | 1 | 2002 | 2615 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6313 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2005 | 5867 | 0.010 |
Why?
|
Orthopedic Procedures | 1 | 2004 | 1288 | 0.010 |
Why?
|
Transcription Factors | 1 | 2011 | 12164 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9144 | 0.010 |
Why?
|
Rats | 1 | 2003 | 24265 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13655 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2002 | 39004 | 0.000 |
Why?
|